Engaging Sales Collateral to Bring New Hope and Treatment for Patients with Diabetic Gastroparesis (Evoke Pharma, EVERSANA™ ENGAGE)
Diabetic gastroparesis is a condition that prevents food from breaking down and moving into the small intestine. It can cause vomiting, nausea, abdominal pain, and bloating, creating discomfort, embarrassment, and frustration for patients.
Startup Evoke Pharma partnered with EVERSANA ENGAGE to create a compelling campaign that demonstrated the clear benefits of Gimoti, the first nasal spray treatment of its kind. The “Spray Away” campaign educated patients and providers about the new treatment for diabetic gastroparesis. The campaign, anchored with the “mist” type canister, highlighted the major differentiation for the new therapy, and included both consumer-facing and clinician-facing websites and patient education brochures.
The “Spray Away” campaign has been successful. Since launch in October 2020, reps provided over 10,000 collateral pieces to healthcare offices across the U.S. The websites received more than 61,000 page views combined since launch and continue to see increased monthly traffic.
